The prevalence of patients with normal post-bronchodilator spirometry that fulfil the criteria for GOLD mild COPD using ECCS predicted equations Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019
Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction? Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015
Pre- and post- bronchodilator FEV1 does not perturb a multidimensional system (IDS) for categorising the clinical impact of COPD: comparison of ERS, BTS and GOLD guidelines Source: Eur Respir J 2003; 22: Suppl. 45, 215s Year: 2003
Concordance among GOLD, NICE and LLN criteria in the spirometry diagnosis of airflow obstruction Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016
Comparison of pre and post-bronchodilator single-breath and re-breathe DLCO values amongst healthy, asthmatic and COPD subjects Source: Annual Congress 2013 –New issues in lung function testing Year: 2013
The effect of adopting new GLI-2012 spirometric reference values on airflow limitation GOLD classification Source: International Congress 2015 – Lung function: waiting to exhale... Year: 2015
Spirometric diagnosis of COPD: is postbronchodilator test reliable? Source: Eur Respir J 2006; 28: Suppl. 50, 39s Year: 2006
Rate of FEV1 decline by FEV1 percent predicted in UPLIFT® and TIOSPIR® Source: International Congress 2016 – Pharmacological management of COPD Year: 2016
Changes in spirometry (FVC and FEV1 ) in a closed population of COPD patients using new standarized values for Mexican people Source: Eur Respir J 2003; 22: Suppl. 45, 69s Year: 2003
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016
COPD or not COPD: Answer in FEV1 Source: International Congress 2016 – From cardiopulmonary interaction to locomotor muscles and dyspnoea in health and disease Year: 2016
The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD Source: International Congress 2014 – COPD exacerbations Year: 2014
Diagnosis of airway obstruction: A comparison between the GLI 2012 reference equations, the NHANES III reference equations and the fixed cut-off for FEV1 /FVC Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care Year: 2013
Changes in FEV1 over time in COPD and the importance of spirometry reference ranges: the devil is in the detail Source: Breathe, 15 (4) 337; 10.1183/20734735.0252-2019 Year: 2019
Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6 Source: Eur Respir J 2006; 27: 378-383 Year: 2006
CAT’ or ’mMRC’ – Which is a better symptom scale in recent GOLD COPD classification? Source: International Congress 2015 – COPD: interesting notes Year: 2015
Lung function testing in the elderly – can we still use FEV1/FVC < 70% as a criterion of COPD? Source: Eur Respir J 2006; 28: Suppl. 50, 613s Year: 2006
Airway obstruction by GOLD and ATS/ERS2005 criteria in Caucasian American pulmonary laboratory patients using NHANESIII and ERS/GLI12 prediction equations Source: International Congress 2014 – The impact of the Global Lung Initiative (GLI) reference equations and spirometry quality in all ages Year: 2014
Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013
Can we predict change in FEV1 (decliners and non-decliners) in ex-smokers with COPD? Source: Eur Respir J 2005; 26: Suppl. 49, 517s Year: 2005